VIM-4 in a Carbapenem-Resistant Strain of Pseudomonas aeruginosa Isolated in Sweden
Open Access
- 1 September 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (9), 3034-3035
- https://doi.org/10.1128/aac.47.9.3034-3035.2003
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Novel Variant ( bla VIM-4 ) of the Metallo-β-Lactamase Gene bla VIM-1 in a Clinical Strain of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2002
- Evaluation of a New Etest for Detecting Metallo-β-Lactamases in Routine Clinical TestingJournal of Clinical Microbiology, 2002
- Emerging carbapenemases in Gram-negative aerobesClinical Microbiology & Infection, 2002
- Metallo-β-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 EnzymeAntimicrobial Agents and Chemotherapy, 2001
- Purification and Biochemical Characterization of the VIM-1 Metallo-β-LactamaseAntimicrobial Agents and Chemotherapy, 2000
- Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical IsolateAntimicrobial Agents and Chemotherapy, 1999
- Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing.1997